The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Evstigneeva O.A.

FGU "Éndokrinologicheskiĭ nauchnyĭ tsentr", Moskva

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Iarovaia I.S.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Andreeva E.N.

Mediko-geneticheskoe otdelenie Moskovskogo oblastnogo NII akusherstva i ginekologii

ESTROGENS REPLACEMENT THERAPY: EFFECT ON HEMODYNAMICS AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TURNER SYNDROME (a review)

Authors:

Evstigneeva O.A., Grigorian O.R., Iarovaia I.S., Andreeva E.N.

More about the authors

Read: 1364 times


To cite this article:

Evstigneeva OA, Grigorian OR, Iarovaia IS, Andreeva EN. ESTROGENS REPLACEMENT THERAPY: EFFECT ON HEMODYNAMICS AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TURNER SYNDROME (a review). Russian Journal of Human Reproduction. 2012;(5):33‑36. (In Russ.)

Recommended articles:
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Depressive diso­rders in women during the meno­pausal transition and meno­pause. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):41-46

References:

  1. Baguet J.P., Douchin S., Pierre H., Rossignol A.M., Bost M., Mallion J.M. Structural and functional abnormalities of large arteries in Turner syndrome. Heart 2005; 91: 1442-1446.
  2. Bechtold S.M., Dalla Pozza R., Becker A., Meidert A., Dohlemann C., Schwarz H.P. Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome. Eur J Pediatr 2004; 163: 158-162.
  3. Berdahl L.D., Wenstrom K.D., Hanson J.W. Web neck anomaly and its association with congenital heart disease. Am J Med Genet 1985; 56: 304-307.
  4. Castro A.V., Okoshi K., Ribeiro S.M., Barbosa M.F., Mattos P.F., Pagliare L., Bueno N.F., Rodrigueiro D.A., Haddad A.L. Cardiovascular assessment of patients with Ullrich-Turner's Syndrome on Doppler echocardiography and magnetic resonance imaging. Ar Qbras Cardiol 2002; 78: 51-58.
  5. Chalard F., Ferey S., Teinturier C., Kalifa G. Aortic dilatation in Turner syndrome: the role of MRI in early recognition. Pediatr Radiol 2005; 35: 323-326.
  6. Clark E.B. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome. Teratology 1984; 29: 355-361.
  7. Dawson-Falk K.L., Wright A.M., Bakker B., Pitlick P.T., Wilson D.M., Rosenfeld R.G. Cardiovascular evaluation in Turner syndrome: utility of MR imaging. Australas Radiol 1992; 36: 204-209.
  8. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Engl J Med 2004; 350: 1387-1397.
  9. Espeland M.A., Applegate W., Furberg C.D., Lefkowitz D., Rice L., Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epid 1995; 142: 1011-1019.
  10. Ferguson-Smith M.A. Karyotype-phenotype correlations in gonadal dys-genesis and their bearing on the pathogenesis of malformations. J Med Genet 1965; 2: 142-155.
  11. Hodis H.N., Mack W.J., Lobo R.A., Shoupe D., Sevanian A., Mahrer P.R., Selzer R.H., Liu Cr.C.R., Liu Ch.C.H., Azen S.P. Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Inter Med 2001; 135: 939-953.
  12. Ho V.B., Bakalov V.K., Cooley M., Van P.L., Hood M.N., Burklow T. R., Bondy C.A. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004; 110: 1694-1700.
  13. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., Hsia J., Hulley S., Herd A., Khan S., Newby L.K., Waters D., Vittinghoff E., Wenger N. Cardiovascular disease outcomes during 6·8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49-57.
  14. Gravholt C.H., Juul S., Naeraa R.W., Hansen J. Morbidity in Turner syndrome. J Clin Epid 1998; 51: 147-158.
  15. Godsland I.F., Manassiev N.A., Felton C.V., Proudler A.J., Crook D., Whitehead M.I., Stevenson J.C. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women. Clin Endocr 2004; 60: 541-549.
  16. Godsland I.F. The influence of female sex steroids on glucose metabolism and insulin action. J Int Med 1996; 738: Suppl: 1-60.
  17. Guyton J.R., Klemp K.F. Transitional features in human atherosclerosis: intimal thickening, cholesterol clefts, and cell loss in human aortic fatty streaks. Am J Path 1993; 143: 1444-1457.
  18. Ostberg J.E., Storry C., Donald A.E., Javad Hosseinzadeh Attar M., Halcox J., Conway G.S. A dose - response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxford) 2007; 66: 4: 557-564.
  19. Lacro R.V., Jones K.L., Benirschke K. Coarctation of the aorta in Turner syndrome: a pathologic study of fetuses with nuchal cystic hygromas, hydrops fetalis, and female genitalia. Pediatrics 1988; 81: 445-451.
  20. Loscalzo M.L., Van P.L., Ho V.B., Bakalov V.K., Rosing D.R., Malone C.A., Dietz H.C., Bondy C.A. Association between fetal lymphedema and congenital cardiovascul defects in Turner syndrome. Pediatrics 2005; 115: 732-735.
  21. Lower G.D. Hormone replacement therapy: prothrombotic vs. protective effects. Pathoph Haem Thromb 2002; 2: 329-332.
  22. Maraschio P., Tupler R., Barbierato L., Dainotti E., Larizza D., Bernardi F., Hoeller H., Garau A., Tiepolo L. An analysis of Xq deletions. Hum Genet 1996; 97: 375-381.
  23. Miyabara S., Nakayama M., Suzumori K., Yonemitsu N., Sugihara H. Developmental analysis of cardiovascular system of 45,X fetuses with cystic hygroma. Am J Med Genet 1997; 68: 135-141.
  24. Nielsen J., Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus (Denmark). Hum Genet 1991; 87: 81-83.
  25. Ostberg J.E., Donald A.E., Halcox JP.J., Storry C., Mc. Carthy C., Conway G.S. Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 2005; 90: 5161-5166.
  26. Pradhan A.D., Manson J.E., Rossouw J.E., Siscovick D.S., Mouton C.P., Rifai N., Wallace R.B., Jackson R.D., Pettinger M.B., Ridker P.M. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288: 980-987.
  27. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. Creactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 2000; 342: 836-843.
  28. Ross J.L., Scott Jr.C., Marttila P., Kowal K., Nass A., Papenhausen P., Abboudi J., Osterman L., Kushner H., Carter P., Ezaki M., Elder F., Wei F., Chen H., Zinn A.R. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001; 86: 5674-5680.
  29. Salonen J.T., Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87: II 56-65.
  30. Salpeter S.R., Walsh J.M., Greyber E., Ormiston T.M., Salpeter E.E. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004; 19: 791-804.
  31. Shiroma K., Ebine K., Tamura S., Yokomuro M., Suzuki H., Takanashi Y. A case of Turner's syndrome associated with partial anomalous pulmonary venous return complicated by dissecting aortic aneurysm and aortic regurgitation. J Cardiovasc Surg (Torino) 1997; 38: 257-259.
  32. Song L., Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atheroscer 2004; 177: 43-51.
  33. Swerdlow A.J., Hermon C., Jacobs P.A., Alberman E., Beral V., Daker M., Fordyce A., Youings S. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. An Human Gen 2001; 65: 177-188.
  34. Surerus E., Huggon I.C., Allan L.D. Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 2003; 22: 264-267.
  35. Turner H.H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938; 23: 566-574.
  36. Ullrich O. Uber typische Kombinationsbilder multipler Abartungen. Z Kinderheilk 1930; 49: 271-276.
  37. Van Wassenaer A.G., Lubbers L.J., Losekoot G. Partial abnormal pulmonary venous return in Turner syndrome. Eur J Pediatr 1988; 148: 101-103.
  38. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.